NCT00577018View on ClinicalTrials.gov

Efficacy and Safety Study of the Effect of Dose-Titration of Prucalopride for The Treatment of Chronic Constipation

PHASE3CompletedINTERVENTIONAL
Enrollment

755

Participants

Timeline

Start Date

August 31, 1998

Primary Completion Date

September 30, 1999

Study Completion Date

September 30, 1999

Conditions
Constipation
Interventions
DRUG

Prucalopride

4 mg o.d.

DRUG

Prucalopride

1 mg o.d. for 2 days, 2 mg o.d. for 2 days and 4 mg o.d. thereafter

OTHER

Placebo

o.d.

Sponsors

Lead Sponsor

Movetis
All Listed Sponsors
lead

Movetis

INDUSTRY